| Name | Title | Contact Details |
|---|
MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.
Hialeah Technology Center is a Hialeah, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Many well-being programs give you tools to manage your health. We go deeper. WellSpark is a leading health and well-being company that administers one of the largest value-based well-being programs in the country. Our well-being portal is certified for information security by the Health Information Trust (HITRUST) Alliance, and our health risk assessment earned the Wellness and Health Promotion certification form the National Committee for Quality Assurance (NCQA). WellSpark delivers a full-suite of well-being products and solutions for businesses, municipalities, and consumers. Participants benefit from robust education to improve health literacy, promote early detection of diseases and provide condition management through coaching, care coordination, social services and more. By understanding any socio-economic and behavioral barriers preventing proper self-care, WellSpark programs can uniquely empower individuals to embrace healthier lifestyles. Lives improve when well-being solutions spark results. Go beyond basic health and well-being with WellSpark Health.
Uroplasty is a global medical company committed to offering transformative treatment options through specialty physicians. Our products are designed to help providers change the lives of their voiding dysfunction patients and strengthen the efficiency of their practices. Uroplasty’s products include the Urgent® PC Neuromodulation System, a non-drug, non-surgical office-based treatment for Overactive Bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence. Urgent PC is an FDA-cleared system that delivers PTNS (Percutaneous Tibial Nerve Stimulation) and is also indicated for the treatment of fecal incontinence outside the US market. Uroplasty also offers Macroplastique®, an injectable urethral bulking agent for female stress urinary incontinence primarily due to intrinsic sphincter deficiency. Female SUI only in U.S.; male and female SUI outside the U.S. Uroplasty products are typically used when a patient’s treatment goals are not met after conservative and/or drug therapies. Providers and patients alike appreciate that Uroplasty products provide low-risk, effective alternatives to invasive surgery. And because these treatments can be delivered in an office or outpatient setting, the end result is that more patients are given the opportunity to transform their lives with successful treatment.
Zufall Health Center is a Dover, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.